BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19698859)

  • 1. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial.
    Hecht-Dolnik M; Barkan H; Taharka A; Loftus J
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):703-11. PubMed ID: 19698859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.
    Shim JK; Choi YS; Oh YJ; Bang SO; Yoo KJ; Kwak YL
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):59-64. PubMed ID: 17599487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?
    Ooi JS; Ramzisham AR; Zamrin MD
    Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):368-72. PubMed ID: 19713332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting.
    Puskas JD; Williams WH; Duke PG; Staples JR; Glas KE; Marshall JJ; Leimbach M; Huber P; Garas S; Sammons BH; McCall SA; Petersen RJ; Bailey DE; Chu H; Mahoney EM; Weintraub WS; Guyton RA
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):797-808. PubMed ID: 12698142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.
    Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG.
    Vanhoonacker J; Ongenae M; Vanoverschelde H; Donadoni R
    Acta Anaesthesiol Belg; 2009; 60(2):91-7. PubMed ID: 19594090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery.
    Ballotta A; Saleh HZ; El Baghdady HW; Gomaa M; Belloli F; Kandil H; Balbaa Y; Bettini F; Bossone E; Menicanti L; Frigiola A; Bellucci C; Mehta RH
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):132-8. PubMed ID: 17599498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity case-matched analysis of off-pump coronary artery bypass grafting in patients with atheromatous aortic disease.
    Sharony R; Grossi EA; Saunders PC; Galloway AC; Applebaum R; Ribakove GH; Culliford AT; Kanchuger M; Kronzon I; Colvin SB
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):406-13. PubMed ID: 14762348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
    Bizzarri F; Scolletta S; Tucci E; Lucidi M; Davoli G; Toscano T; Neri E; Muzzi L; Frati G
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1181-5. PubMed ID: 11726894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.
    Casati V; Della Valle P; Benussi S; Franco A; Gerli C; Baili P; Alfieri O; D'Angelo A
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):83-91. PubMed ID: 15224025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beating heart versus conventional reoperative coronary artery bypass surgery.
    Mishra Y; Wasir H; Kohli V; Meharwal ZS; Bapna R; Mehta Y; Trehan N
    Indian Heart J; 2002; 54(2):159-63. PubMed ID: 12086378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of body core temperature on blood loss and transfusion requirements during off-pump coronary artery bypass grafting: a comparison of 3 warming systems.
    Hofer CK; Worn M; Tavakoli R; Sander L; Maloigne M; Klaghofer R; Zollinger A
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):838-43. PubMed ID: 15821652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery.
    Kang W; Theman TE; Reed JF; Stoltzfus J; Weger N
    J Surg Educ; 2007; 64(2):88-92. PubMed ID: 17462208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease.
    Mack MJ; Pfister A; Bachand D; Emery R; Magee MJ; Connolly M; Subramanian V
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):167-73. PubMed ID: 14752427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery bypass grafting "on pump": role of three-day discharge.
    Ott RA; Gutfinger DE; Miller MP; Selvan A; Codini MA; Alimadadian H; Tanner TM
    Ann Thorac Surg; 1997 Aug; 64(2):478-81. PubMed ID: 9262597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure.
    Surgenor SD; DeFoe GR; Fillinger MP; Likosky DS; Groom RC; Clark C; Helm RE; Kramer RS; Leavitt BJ; Klemperer JD; Krumholz CF; Westbrook BM; Galatis DJ; Frumiento C; Ross CS; Olmstead EM; O'Connor GT
    Circulation; 2006 Jul; 114(1 Suppl):I43-8. PubMed ID: 16820613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resource utilization in on- and off-pump coronary artery surgery: factors influencing postoperative length of stay--an experience of 1,746 consecutive patients undergoing fast-track cardiac anesthesia.
    Scott BH; Seifert FC; Grimson R; Glass PS
    J Cardiothorac Vasc Anesth; 2005 Feb; 19(1):26-31. PubMed ID: 15747265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.